Table 3 Promoter methylation at DAPK, MGMT, hMLH1, OR beta, and p16 at week 0 and week 6 in 10 of the group 1 patients.

	Week 0 (n = 10) (No (%))	Week 6 (n = 10) (No (%))
DAPK	2 (20)	1 (10)
MGMT	0	2 (20)
hMLH1	1 (10)	1 (10)
OR beta	6 (60)	5 (50)
p16	0	0
E‐cadherin	5 (50)	2 (20)

DAPK, DAP kinase; MGMT, O⁶‐methyl‐guanine methyltransferase; hMLH1, human Mut L homologue; OR beta, oestrogen receptor beta.